These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 1727796

  • 1. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
    Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, Erlinger S, Benhamou JP.
    Hepatology; 1992 Jan; 15(1):32-6. PubMed ID: 1727796
    [Abstract] [Full Text] [Related]

  • 2. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G, Rugge M, Brollo L, Pontisso P, Noventa F, Guido M, Alberti A, Realdi G.
    Hepatology; 1986 Jan; 6(2):167-72. PubMed ID: 3957228
    [Abstract] [Full Text] [Related]

  • 3. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N, Kırdar S, Uzun N, Eyigör M, Sayan M.
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [Abstract] [Full Text] [Related]

  • 4. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y, Chen P, Xia JR, Zhang LP.
    Genet Mol Res; 2017 Feb 23; 16(1):. PubMed ID: 28252163
    [Abstract] [Full Text] [Related]

  • 5. High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B.
    Norder H, Brattström C, Magnius L.
    J Med Virol; 1989 Apr 23; 27(4):322-8. PubMed ID: 2656911
    [Abstract] [Full Text] [Related]

  • 6. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A, Canini L, Gozlan J, Lascoux-Combe C, Miailhes P, Fonquernie L, Girard PM, Lacombe K.
    J Clin Virol; 2017 Oct 23; 95():55-60. PubMed ID: 28869890
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T, Sagnelli E, Rapicetta M, Felaco FM, Filippini P, Annella T, Petruzziello A, Chionne P, Sarrecchia B, Piccinino F.
    Hepatogastroenterology; 1992 Feb 23; 39(1):62-5. PubMed ID: 1568710
    [Abstract] [Full Text] [Related]

  • 8. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
    Matthews GV, Ali RJ, Avihingsanon A, Amin J, Hammond R, Bowden S, Lewin SR, Sasadeusz J, Littlejohn M, Locarnini SL, Ruxrungtham K, Dore GJ.
    PLoS One; 2013 Feb 23; 8(4):e61297. PubMed ID: 23593455
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J, Chlumská A, Zichová M, Helm R, Mankovecký L, König J.
    Sb Lek; 1993 Feb 23; 94(4):317-25. PubMed ID: 7992018
    [Abstract] [Full Text] [Related]

  • 10. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence.
    Bahn A, Gerner P, Martiné U, Bortolotti F, Wirth S.
    J Hepatol; 1997 Dec 23; 27(6):973-8. PubMed ID: 9453421
    [Abstract] [Full Text] [Related]

  • 11. Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Su IJ, Lai MY, Hsu HC, Chen DS, Yang PM, Chuang SM, Sung JL.
    J Hepatol; 1986 Dec 23; 3(2):182-9. PubMed ID: 3794299
    [Abstract] [Full Text] [Related]

  • 12. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B.
    Costa J, López-Labrador FX, Sánchez-Tapias JM, Mas A, Vilella A, Olmedo E, Vidal J, Jimenez de Anta MT, Rodés J.
    J Hepatol; 1995 Jan 23; 22(1):35-42. PubMed ID: 7751585
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg/anti-HBe status.
    Berris B, Sampliner RE, Sooknanan R, Feinman SV.
    J Med Virol; 1987 Nov 23; 23(3):233-9. PubMed ID: 3430143
    [Abstract] [Full Text] [Related]

  • 14. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS, Lai MY, Lee SC, Yang PM, Sheu JC, Sung JL.
    J Med Virol; 1986 May 23; 19(1):87-94. PubMed ID: 3701304
    [Abstract] [Full Text] [Related]

  • 15. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
    Lindh G.
    Scand J Infect Dis Suppl; 1986 May 23; 50():1-45. PubMed ID: 3468608
    [Abstract] [Full Text] [Related]

  • 16. [Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].
    Dou YL, Cheng XQ, Li YZ, Han JH, Ni AP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug 23; 27(8):709-11. PubMed ID: 17172114
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus DNA in liver tissue of chronic HBsAg carriers in childhood and its relationship to other viral markers.
    Wirth S, Keller KM, Schaefer E, Zabel B.
    J Pediatr Gastroenterol Nutr; 1992 May 23; 14(4):431-5. PubMed ID: 1517947
    [Abstract] [Full Text] [Related]

  • 18. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
    Xu B, Yao G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun 23; 11(2):117-20. PubMed ID: 15619813
    [Abstract] [Full Text] [Related]

  • 19. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
    Roushan MR, Bijani A, Ramzaninejad S, Roushan MH, Amiri MJ, Baiani M.
    J Clin Virol; 2012 Sep 23; 55(1):30-3. PubMed ID: 22727680
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R, Cinar K, Seven G, Bozkus Y, Elhan A, Bozdayi M, Yurdaydin C, Bahar K.
    J Viral Hepat; 2012 Mar 23; 19(3):220-6. PubMed ID: 22329377
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.